Evidence Against an Important Role of Plasma Insulin and Glucagon Concentrations in the Increase in EGP Caused by SGLT2 Inhibitors.


Journal

Diabetes
ISSN: 1939-327X
Titre abrégé: Diabetes
Pays: United States
ID NLM: 0372763

Informations de publication

Date de publication:
04 2020
Historique:
received: 05 08 2019
accepted: 01 01 2020
pubmed: 10 1 2020
medline: 4 8 2020
entrez: 10 1 2020
Statut: ppublish

Résumé

Sodium-glucose cotransport 2 inhibitors (SGLT2i) lower plasma glucose but stimulate endogenous glucose production (EGP). The current study examined the effect of dapagliflozin on EGP while clamping plasma glucose, insulin, and glucagon concentrations at their fasting level. Thirty-eight patients with type 2 diabetes received an 8-h measurement of EGP ([3-

Identifiants

pubmed: 31915153
pii: db19-0770
doi: 10.2337/db19-0770
pmc: PMC7085246
doi:

Substances chimiques

Benzhydryl Compounds 0
Blood Glucose 0
Glucosides 0
Insulin 0
Sodium-Glucose Transporter 2 Inhibitors 0
dapagliflozin 1ULL0QJ8UC
Glucagon 9007-92-5

Banques de données

ClinicalTrials.gov
['NCT02592421']

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

681-688

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK107680
Pays : United States

Informations de copyright

© 2020 by the American Diabetes Association.

Références

Diabetes. 2016 May;65(5):1190-5
pubmed: 26861783
Diabetes. 2017 Jul;66(7):1999-2006
pubmed: 28428225
Nat Med. 2015 May;21(5):512-7
pubmed: 25894829
Diabetes. 1999 May;48(5):1198-214
pubmed: 10331429
Nat Rev Nephrol. 2017 Jan;13(1):11-26
pubmed: 27941935
Arch Biochem Biophys. 1982 Jan;213(1):169-76
pubmed: 6120679
Diabetologia. 2019 Jun;62(6):1011-1023
pubmed: 30903205
Nat Rev Endocrinol. 2017 Oct;13(10):572-587
pubmed: 28731034
J Clin Invest. 2014 Feb;124(2):499-508
pubmed: 24463454
Gastroenterology. 1985 Jan;88(1 Pt 1):80-5
pubmed: 2856879
Surgery. 1985 Mar;97(3):285-9
pubmed: 2858130
Clin Sci (Lond). 1991 Aug;81(2):169-75
pubmed: 1653660
Diabetes. 2018 Jun;67(6):1182-1189
pubmed: 29602791
J Clin Invest. 2014 Feb;124(2):509-14
pubmed: 24463448
Am J Physiol Renal Physiol. 2015 Dec 1;309(11):F889-900
pubmed: 26354881
Diabetes Care. 2020 Jun;43(6):1234-1241
pubmed: 32220916
J Clin Endocrinol Metab. 2019 Jan 1;104(1):193-201
pubmed: 30137410

Auteurs

Mariam Alatrach (M)

Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, TX.

Nitchakarn Laichuthai (N)

Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.

Robert Martinez (R)

Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, TX.

Christina Agyin (C)

Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, TX.

Ali Muhammed Ali (AM)

Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, TX.

Hussein Al-Jobori (H)

Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, TX.

Olga Lavynenko (O)

Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, TX.

John Adams (J)

Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, TX.

Curtis Triplitt (C)

Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, TX.

Ralph DeFronzo (R)

Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, TX albarado@uthscsa.edu.

Eugenio Cersosimo (E)

Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, TX.

Muhammad Abdul-Ghani (M)

Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, TX.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH